Clinical Trials Browser

OTHER × ADI PEG20 × Gastrointestinal × Clear all

NCT06034977 2023-09-13

Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04965714 2023-02-16

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

Phase 2 Withdrawn

Gastrointestinal

Resectable Hepatocellular Carcinoma